AG真人官方

Experience Burcon's next-generation plant protein innovations at booth S4066

Vancouver, British Columbia--(Newsfile Corp. - July 2, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is excited to unveil a Café Latte plant-based protein beverage concept at the upcoming Institute of Food Technologists Annual Meeting and Exposition ("IFT FIRST") in Chicago, IL, from July 13-16 in exhibit booth S4066.

Cold Café Latte beverage containing plant proteins photo

Note: The 2025 IFT FIRST food, beverage, foodservice, nutrition and nutraceuticals tradeshow will be held in Chicago July 13-16 and next-generation plant proteins will be front and center. Plant protein innovator Burcon NutraScience (Booth S4066) will feature its range of 90%+ pure pea, sunflower, canola, hemp and fava plant-based proteins with all featuring neutral flavor and aroma, and smooth mouthfeel. During the show, Burcon will be sampling a tasty cold Café Latte beverage containing 10 grams of high-purity pea and sunflower seed plant protein in a standard serving. IFT First is presented annually by the Institute of Food Technologists. 

To view an enhanced version of this graphic, please visit:

IFT FIRST attendees will have the opportunity to sample the rich, coffee-inspired beverage made with Burcon's proprietary blend of Peazazz®C pea protein and Solatein™ sunflower protein. The Café Latte contains 10 grams of plant protein in an eight-ounce serving showcasing the clean taste, smooth texture, and superior functionality of Burcon's high-purity protein ingredients—delivering an exceptional sensory experience.

"We're thrilled to highlight our unique plant protein solutions in a Café Latte format," said Kip Underwood, Burcon's chief executive officer. "Consumer preferences continue to evolve, but coffee remains a beloved and timeless flavor—making it the perfect showcase for Burcon's next-generation proteins."

In addition to the Café Latte, Burcon will exhibit its full portfolio of innovative plant-based proteins, each offering 90%+ protein purity, neutral flavor, and excellent performance for food, beverage, foodservice, nutritional, and nutraceutical applications.

Featured Burcon protein ingredients on display at IFT FIRST include:

• Peazazz® C - 90%+ pea protein
• Puratein® C - 90%+ canola protein
• Solatein™ - 90%+ sunflower protein and a sunflower protein concentrate
• HPI95 - 90%+ hempseed protein
• FavaPro™ - 90%+ fava protein

Experience the next generation of plant-based proteins at Burcon booth S4066 at IFT FIRST 2025 in Chicago, July 13-16, and learn more at . For product samples, sales inquiries or to schedule a meeting with the team at IFT FIRST, contact Benoit Keppenne at [email protected].

About Burcon NutraScience Corporation

Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry. Our commercial ingredients offer superior taste, texture, and functionality-ideal for formulators seeking next-generation protein solutions. Backed by over two decades of innovation, Burcon holds an extensive patent portfolio covering novel proteins derived from pea, canola, soy, hemp, sunflower, and other plant sources. As a key player in the rapidly growing plant-based market, Burcon is committed to sustainability and to creating best-in-class protein solutions that are better for people and the planet. Learn more at .

Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2025 and its other public filings with Canadian securities regulators on SEDAR+ at . This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.

To view the source version of this press release, please visit